Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-13 11:47:38 UTC
Update Date2022-03-07 02:57:13 UTC
HMDB IDHMDB0041914
Secondary Accession Numbers
  • HMDB41914
Metabolite Identification
Common NameKetophenylbutazone
DescriptionKetophenylbutazone, also known as kebuzonum or quebuzona, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Based on a literature review a significant number of articles have been published on Ketophenylbutazone.
Structure
Data?1563863713
Synonyms
ValueSource
1,2-Diphenyl-4-(gamma-ketobutyl)-3,5-pyrazolidinedioneChEBI
4-(3-Oxobutyl)-1,2-diphenyl-3,5-pyrazolidinedioneChEBI
KebuzonumChEBI
KetophenylbutazonumChEBI
QuebuzonaChEBI
KebuzoneKegg
1,2-Diphenyl-4-(g-ketobutyl)-3,5-pyrazolidinedioneGenerator
1,2-Diphenyl-4-(γ-ketobutyl)-3,5-pyrazolidinedioneGenerator
ChebutanHMDB
PhloguronHMDB
ChetofenilbutazoneHMDB
CopireneHMDB
RachetonHMDB
ChetofenilbutazonHMDB
KetazonHMDB
KebuzonHMDB
KetophenylbutazoneChEBI
Chemical FormulaC19H18N2O3
Average Molecular Weight322.3578
Monoisotopic Molecular Weight322.131742452
IUPAC Name4-(3-oxobutyl)-1,2-diphenylpyrazolidine-3,5-dione
Traditional Namekebuzone
CAS Registry Number853-34-9
SMILES
CC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C1
InChI Identifier
InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3
InChI KeyLGYTZKPVOAIUKX-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassNot Available
Direct ParentBenzene and substituted derivatives
Alternative Parents
Substituents
  • Monocyclic benzene moiety
  • Pyrazolidinone
  • 1,3-dicarbonyl compound
  • Pyrazolidine
  • Carboxylic acid hydrazide
  • Ketone
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Azacycle
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.17 mg/mL at 20 °CNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.11 g/LALOGPS
logP1.99ALOGPS
logP2.7ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)4.17ChemAxon
pKa (Strongest Basic)-7.3ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area57.69 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity89.37 m³·mol⁻¹ChemAxon
Polarizability33.64 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+175.89130932474
DeepCCS[M-H]-173.53330932474
DeepCCS[M-2H]-207.30530932474
DeepCCS[M+Na]+182.53530932474
AllCCS[M+H]+176.232859911
AllCCS[M+H-H2O]+173.032859911
AllCCS[M+NH4]+179.132859911
AllCCS[M+Na]+180.032859911
AllCCS[M-H]-178.232859911
AllCCS[M+Na-2H]-177.832859911
AllCCS[M+HCOO]-177.532859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
KetophenylbutazoneCC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C13897.7Standard polar33892256
KetophenylbutazoneCC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C12803.3Standard non polar33892256
KetophenylbutazoneCC(=O)CCC1C(=O)N(N(C1=O)C1=CC=CC=C1)C1=CC=CC=C12582.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Ketophenylbutazone,1TMS,isomer #1CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C2675.9Semi standard non polar33892256
Ketophenylbutazone,1TMS,isomer #1CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C2705.7Standard non polar33892256
Ketophenylbutazone,1TMS,isomer #2C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C2639.2Semi standard non polar33892256
Ketophenylbutazone,1TMS,isomer #2C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C2646.5Standard non polar33892256
Ketophenylbutazone,1TBDMS,isomer #1CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C2914.4Semi standard non polar33892256
Ketophenylbutazone,1TBDMS,isomer #1CC(=CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C2904.9Standard non polar33892256
Ketophenylbutazone,1TBDMS,isomer #2C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C2874.1Semi standard non polar33892256
Ketophenylbutazone,1TBDMS,isomer #2C=C(CCC1C(=O)N(C2=CC=CC=C2)N(C2=CC=CC=C2)C1=O)O[Si](C)(C)C(C)(C)C2840.8Standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Ketophenylbutazone GC-MS (Non-derivatized) - 70eV, Positivesplash10-000x-9451000000-20f6c914fed4069572072017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Ketophenylbutazone GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Positive-QTOFsplash10-05fr-0019000000-c5e4c3ccd5cce60874be2017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Positive-QTOFsplash10-0avi-4179000000-25bd6883a89d363eb6322017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Positive-QTOFsplash10-000x-9230000000-5de6d5996d83a5d16f712017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Negative-QTOFsplash10-00di-0029000000-7b443a0fcd3e3a5df4072017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Negative-QTOFsplash10-0kmi-5579000000-5ea363b653693ed3125c2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Negative-QTOFsplash10-0006-9500000000-706ef9e0b02460c9ff452017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Positive-QTOFsplash10-00di-0009000000-33d59492e0378fd901712021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Positive-QTOFsplash10-00di-0039000000-36491d2e363fb42d80752021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Positive-QTOFsplash10-07bf-9800000000-f0dc377845da2da2132c2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 10V, Negative-QTOFsplash10-00di-0009000000-c0122f56c13f37edfeb32021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 20V, Negative-QTOFsplash10-0umi-0194000000-144aa7f826627fd268052021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Ketophenylbutazone 40V, Negative-QTOFsplash10-053u-9200000000-9967204f9ae136396b562021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane (predicted from logP)
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB08940
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID3692
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkKebuzone
METLIN IDNot Available
PubChem Compound3824
PDB IDNot Available
ChEBI ID31749
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. SIBLIKOVA O, CERNA M, HAIS IM: [Contribution to the metabolism of ketophenylbutazone. II. Ketophenylbutazone metabolites in urine]. Cesk Farm. 1962 Mar;11:123-6. [PubMed:13912486 ]
  2. Zhivkova ZD, Russeva VN: Binding of kebuzone to human serum albumin studied by high performance liquid affinity chromatography. Arzneimittelforschung. 2000 Mar;50(3):272-5. [PubMed:10758780 ]
  3. CUGURRA F, BRAMBILLA G: [Comparison between phenylbutazone and ketophenylbutazone]. Arch Ital Sci Farmacol. 1960 Jul;10:195-207. [PubMed:13718791 ]
  4. SIBLIKOVA O, VACHEK J, CERNA M, TESAREK B, VITULOVA V: [Contribution to the metabolism of ketophenylbutazone. I]. Cesk Farm. 1962 Mar;11:118-23. [PubMed:13912489 ]
  5. SALVI V: [CLINICAL EXPERIENCES WITH THE USE OF KETOPHENYLBUTAZONE]. Minerva Med. 1963 Sep 8;54:2554-6. [PubMed:14089873 ]
  6. Horakova Z, Metys J, Cepelak V: [Influence of phenylbutazone and ketophenylbutazone on the gastrointestinal tract]. Therapie. 1965 May-Jun;20(3):617-30. [PubMed:4953937 ]
  7. Huvar A, Sitar J, Kubistova J: [Time of onset of changes in the renographic curve following administration of ketophenylbutazone]. Vnitr Lek. 1969 Nov;15(11):1070-5. [PubMed:5364826 ]
  8. Nielsen GH, Holmen-Christensen H: Plasma concentrations of monophenylbutazone, phenylbutazone and ketophenylbutazone after intravenous administration to rats and mice. Acta Pharmacol Toxicol (Copenh). 1967;25:Suppl 4:42. [PubMed:5630939 ]
  9. Sitar J: [Further experiences with suppression of anginal pain with ketophenylbutazone]. Vnitr Lek. 1968 Sep;14(9):899-904. [PubMed:5680889 ]
  10. Huvar A, Sitar J: [Effect of ketophenylbutazone on the renographic tracing examined with hippuran I-131]. Vnitr Lek. 1969 Apr;15(4):326-31. [PubMed:5780934 ]
  11. Rejholec V: [Some new possibilities for the use of ketophenylbutazone (Ketazon-Spofa) in rheumatology]. Reumatizam. 1966;13(6):205-9. [PubMed:5973922 ]
  12. Queisnerova M, Siblikova O, Veverkova M, Macek K, Nemecek O: [Biotransformation of ketophenylbutazone in vitro]. Cesk Farm. 1967 Jun;16(5):219-22. [PubMed:6077826 ]